ESC 365 - Targeting clonal hematopoiesis in atherosclerosis: the case for primary prevention

HFA Premium Access

Targeting clonal hematopoiesis in atherosclerosis: the case for primary prevention

Session: Clonal hematopoiesis of indeterminate potential in cardiovascular disease: from atherosclerosis to heart failure

Topic: Drugs, Drug Targets

Speaker: Professor J. Fuster (Madrid, ES)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Professor Jose Javier Fuster

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)

8 presentations

2 followers

3 more presentations in this session

Clonal hematopoiesis: a novel approach to prevent heart failure

Speaker: Doctor D. Bromage (London, GB)

Clonal hematopoiesis in ischaemic heart failure: cause or effect?

Speaker: Assistant Professor W. Abplanalp (Frankfurt, DE)

Clonal hematopoiesis of indeterminate potential in cardiovascular disease: from atherosclerosis to heart failure - discussion

Access the full session

Clonal hematopoiesis of indeterminate potential in cardiovascular disease: from atherosclerosis to heart failure

Speakers: Professor J. Fuster, Doctor D. Bromage, Assistant Professor W. Abplanalp

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources